Table 2.
Laboratory examinations of patients associated with the different norovirus genotypes
| Total | GII.4 | Othersa | Untype | ||
|---|---|---|---|---|---|
| GII.4 Sydney[P31] | GII. 4 Sydney [P16] | ||||
| Total number of patients | 168 (100.0%) | 131 (78.0%) | 20 (11.9%) | 8 (4.8%) | 9 (5.4%) |
| hs-CRP (0–10 mg/L) | 1.3 (0.4–5.0) | 1.2 (0.3–5.1) | 2.7 (0.4–5.4) | 1.1 (0.5–6.2) | 1.2 (0.5–9.5) |
| WBC (3.5–9.5 × 109/L) | 9.6 (7.0–12.8) | 9.67 (6.9–13.4) | 10.2 (7.5–12.1) | 12.38 (8.1–20.1) | 7.4 (6.8–9.3) |
| NEUT (1.8–6.3 × 109/L) | 5.1 (2.64–9.21) | 4.9 (2.6–9.3) | 5.4 (2.8–8.1) | 9.7 (4.0–17.9) | 4.0 (1.2–6.7) |
| LYMPH (1.1–3.2 × 109/L) | 3.0 (1.9–4.5) | 2.9 (1.9–4.6) | 3.9 (2.9–4.3) | 2.5 (0.9–5.6) | 2.1 (1.4–4.2) |
| RBC (4.0–4.5 × 109/L) | 4.7 (4.5–4.9) | 4.7 (4.5–4.9) | 4.6 (4.4–4.9) | 5.1 (4.8–5.2) | 4.65 (4.6–4.9) |
| PLT (125–350 × 109/L) | 325 (272.5–392.5) | 332 (273.5–400.0) | 314 (268–438.3) | 314 (202.0–367.0) | 329.0 (234.0–368.0) |
| Na+ (137–147 mmol/L) | 135.9 (134.4–137.6) | 136.0 (134.3–137.6) | 134.7 (132.6–135.6) | 139.2 (137.1–140.7)b | 135.55 (133.7–137.3) |
| Cl− (99–110 mmol/L) | 102.25 (100.3–105.0) | 103 (99.7–105.3) | 102.3 (99.9–105.1) | 105.5 (104.9–107.1)c | 101.7 (97.4–106.2) |
| LDH (180–430 U/L) | 410.4 (310.7–472.2) | 413.6 (329.4–488.7) | 412 (337.9–467.0) | 340.2 (291.1–427.9) | 294.5 (234.9–411.4) |
| AST (15–40 U/L) | 41.0 (34.0–48.0) | 41.0 (34.3–48.0) | 39.0 (31.5–51.0) | 35 (25.3–60.5) | 40.5 (30.3–59.0) |
| HBDH (72–182 U/L) | 226.0 (197.0–249.5) | 229.0 (208.5–259.0) | 216.0 (184.3–241.0) | 222.5 (166.0–262.5) | 200.0 (182.8–233.0) |
| CK-MB (0–25 U/L) | 39.0 (29.0–47.0) | 40.0 (30.5–47.0) | 35.0 (22.0–63.5) | 27.5 (20.0–86.5) | 44.5 (40.3–45.8) |
| FOBT | 24 (14.3%) | 20 (15.3%) | 2 (10.0%) | 2 (25.0%) | 0 (0.0%) |
hs-CRP high-sensitivity C-reactive protein, WBC white blood cell, NEUT neutrophils, LYMPH lymphocytes, RBC red blood cell, PLT platelets, Na sodium, Cl chloride, LDH lactate dehydrogenase, AST aspartate aminotransferase HBDH hydroxybutyrate dehydrogenase, CK-MB creatine kinase isoenzyme, FOBT foecal occult blood test
aThe “Others” group contained three genotypes: GII.2[P16], GII.6[P7] and GII.13[P21]
bp = 0.003 < 0.05: GII.4 (135.8; IQR: 134.2–137.4) vs. Others
cp = 0.007 < 0.05: GII.4 (102.3; IQR: 99.9–105.1) vs. Others